best performing stocks in the large cap from jan 2012 to jul 2013

Alnylam Pharmaceuticals (ALNY) had the highest return between January 1, 2012 and July 31, 2013 by a large-cap US stock, returning 454.3%.

ASSET DATE % RETURN
Alnylam Pharmaceuticals (ALNY)
1/1/2012 - 7/31/2013
454.26%
Regeneron Pharmaceuticals (REGN)
1/1/2012 - 7/31/2013
377.9%
Tesla (TSLA)
1/1/2012 - 7/31/2013
364%
Genmab A-S (GMAB)
1/1/2012 - 7/31/2013
346.48%
Insmed (INSM)
1/1/2012 - 7/31/2013
254.49%
Netflix (NFLX)
1/1/2012 - 7/31/2013
247.87%
Zillow (ZG)
1/1/2012 - 7/31/2013
228.35%
Cheniere Energy (LNG)
1/1/2012 - 7/31/2013
221.37%
Booz Allen Hamilton (BAH)
1/1/2012 - 7/31/2013
200.34%
Corpay (CPAY)
1/1/2012 - 7/31/2013
199.53%
Gilead Sciences (GILD)
1/1/2012 - 7/31/2013
196.19%
Smurfit WestRock (SW)
1/1/2012 - 7/31/2013
194.66%
Builders FirstSource (BLDR)
1/1/2012 - 7/31/2013
180.95%
Pilgrims Pride (PPC)
1/1/2012 - 7/31/2013
180.74%
Westlake Chemical (WLK)
1/1/2012 - 7/31/2013
169.72%
Nomura Holdings Inc ADR (NMR)
1/1/2012 - 7/31/2013
165.92%
Guidewire Software (GWRE)
1/1/2012 - 7/31/2013
161.25%
Seagate Technology (STX)
1/1/2012 - 7/31/2013
158.9%
Delta Air Lines (DAL)
1/1/2012 - 7/31/2013
157.96%
Illumina (ILMN)
1/1/2012 - 7/31/2013
157.48%
Lloyds Banking Group PLC ADR (LYG)
1/1/2012 - 7/31/2013
157.41%
PulteGroup (PHM)
1/1/2012 - 7/31/2013
157.03%
Bank of America (BAC)
1/1/2012 - 7/31/2013
155.56%
Apollo Global Management LLC Class A (APO)
1/1/2012 - 7/31/2013
153.47%
Constellation Brands Inc Class A (STZ)
1/1/2012 - 7/31/2013
148.52%
Large-cap stocks are treated as having a market cap of $10B+.